This inventor holds 2 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignee: Erydel S.p.a.. Active years: 2014-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2020
Title: Sara Biagiotti: Innovator in Drug Delivery and Genetic Research
Introduction
Sara Biagiotti is a prominent inventor based in Tavullia, Italy. She has made significant contributions to the fields of drug delivery systems and genetic research, holding a total of 2 patents. Her work focuses on innovative methods that enhance treatment efficacy for patients with specific medical conditions.
Latest Patents
One of her latest patents is titled "Method of evaluating the response of ataxia telangiectasia patients to glucocorticoids treatment." This invention presents a novel procedure for assessing how patients affected by Ataxia Telangiectasia (A-T) respond to glucocorticoid treatment. The procedure involves the qualitative and/or quantitative identification of a specific mRNA variant of the ATM gene in the blood of these patients, which is produced by non-canonical splicing induced by glucocorticoids. This mRNA variant expression has been shown to correlate with positive treatment responses.
Another significant patent is the "Drug delivery system," which explores the use of red blood cells as effective drug delivery mechanisms. This system involves incorporating proteins within red blood cells that form affinity complexes with desired drugs, preventing them from diffusing out and enhancing their therapeutic potential.
Career Highlights
Sara Biagiotti is currently associated with Erydel S.p.a., where she continues to innovate in the field of drug delivery and genetic research. Her work has garnered attention for its potential to improve treatment outcomes for patients with complex medical conditions.
Collaborations
Throughout her career, Sara has collaborated with notable colleagues, including Mauro Magnani and Luigia Rossi. These partnerships have contributed to her success and the advancement of her research initiatives.
Conclusion
Sara Biagiotti stands out as a leading inventor in the realms of drug delivery and genetic evaluation. Her innovative patents reflect her commitment to improving patient care and treatment methodologies. Her contributions are paving the way for future advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile